IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 334 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,485,950 | -27.9% | 84,961 | -33.7% | 0.02% | -17.9% |
| Q4 2022 | $4,837,204 | +55.3% | 128,070 | +81.9% | 0.03% | +55.6% |
| Q3 2022 | $3,114,000 | -43.7% | 70,408 | -52.9% | 0.02% | -47.1% |
| Q2 2022 | $5,530,000 | +56.3% | 149,388 | +56.4% | 0.03% | +13.3% |
| Q1 2022 | $3,538,000 | -60.9% | 95,530 | -67.9% | 0.03% | -65.1% |
| Q4 2021 | $9,043,000 | +210.8% | 297,182 | +242.6% | 0.09% | +132.4% |
| Q3 2021 | $2,910,000 | -59.0% | 86,754 | -51.3% | 0.04% | -53.8% |
| Q2 2021 | $7,106,000 | +59.4% | 178,142 | +125.9% | 0.08% | +31.1% |
| Q4 2020 | $4,458,000 | +51.1% | 78,852 | +26.8% | 0.06% | +38.6% |
| Q3 2020 | $2,951,000 | +1061.8% | 62,182 | +1346.1% | 0.04% | +1000.0% |
| Q2 2020 | $254,000 | -85.8% | 4,300 | -88.7% | 0.00% | -91.7% |
| Q1 2020 | $1,792,000 | -13.6% | 37,907 | +10.5% | 0.05% | +26.3% |
| Q4 2019 | $2,073,000 | +495.7% | 34,314 | +490.4% | 0.04% | +442.9% |
| Q3 2019 | $348,000 | -88.1% | 5,812 | -87.3% | 0.01% | -87.0% |
| Q2 2019 | $2,936,000 | -38.1% | 45,684 | -21.8% | 0.05% | -64.7% |
| Q1 2019 | $4,741,000 | +9777.1% | 58,403 | +6220.7% | 0.15% | +5000.0% |
| Q3 2018 | $48,000 | -94.6% | 924 | -95.4% | 0.00% | -94.2% |
| Q1 2018 | $882,000 | -32.6% | 20,015 | -23.1% | 0.05% | -25.7% |
| Q4 2017 | $1,309,000 | +291.9% | 26,017 | +294.8% | 0.07% | +268.4% |
| Q3 2017 | $334,000 | -50.5% | 6,590 | -50.3% | 0.02% | -55.8% |
| Q2 2017 | $675,000 | -60.9% | 13,264 | -63.3% | 0.04% | -68.8% |
| Q4 2016 | $1,728,000 | +100.0% | 36,134 | -2.6% | 0.14% | +176.0% |
| Q2 2016 | $864,000 | +85.4% | 37,083 | +222.6% | 0.05% | +85.2% |
| Q1 2016 | $466,000 | +565.7% | 11,496 | +916.4% | 0.03% | +575.0% |
| Q4 2015 | $70,000 | – | 1,131 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |